Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 20 studies | 50% ± 19% | |
peripheral blood | 18 studies | 42% ± 10% | |
intestine | 11 studies | 43% ± 22% | |
kidney | 9 studies | 46% ± 18% | |
brain | 8 studies | 32% ± 20% | |
liver | 6 studies | 41% ± 4% | |
heart | 5 studies | 25% ± 8% | |
uterus | 5 studies | 66% ± 10% | |
adipose | 5 studies | 34% ± 14% | |
skin | 5 studies | 55% ± 22% | |
lymph node | 5 studies | 54% ± 20% | |
breast | 5 studies | 58% ± 13% | |
bone marrow | 4 studies | 38% ± 12% | |
eye | 4 studies | 35% ± 18% | |
esophagus | 4 studies | 55% ± 23% | |
pancreas | 4 studies | 29% ± 4% | |
prostate | 4 studies | 49% ± 10% | |
placenta | 3 studies | 76% ± 8% | |
adrenal gland | 3 studies | 30% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 65969.58 | 180 / 180 | 100% | 373.22 | 430 / 430 |
esophagus | 100% | 34163.01 | 1444 / 1445 | 100% | 293.14 | 183 / 183 |
uterus | 100% | 65881.22 | 170 / 170 | 99% | 329.87 | 455 / 459 |
lung | 100% | 36195.27 | 576 / 578 | 99% | 298.65 | 1144 / 1155 |
thymus | 100% | 30828.52 | 650 / 653 | 99% | 523.29 | 598 / 605 |
breast | 100% | 50699.00 | 459 / 459 | 98% | 292.82 | 1094 / 1118 |
bladder | 100% | 49678.81 | 21 / 21 | 97% | 228.83 | 489 / 504 |
prostate | 100% | 35169.74 | 245 / 245 | 96% | 178.11 | 480 / 502 |
intestine | 97% | 38808.85 | 940 / 966 | 98% | 184.57 | 518 / 527 |
kidney | 98% | 22853.18 | 87 / 89 | 96% | 239.13 | 864 / 901 |
skin | 100% | 56627.14 | 1808 / 1809 | 92% | 146.66 | 433 / 472 |
stomach | 92% | 25090.85 | 332 / 359 | 99% | 205.96 | 282 / 286 |
pancreas | 97% | 19480.72 | 317 / 328 | 94% | 255.03 | 168 / 178 |
liver | 98% | 20258.20 | 222 / 226 | 90% | 121.84 | 367 / 406 |
brain | 43% | 5069.10 | 1147 / 2642 | 94% | 161.24 | 666 / 705 |
adrenal gland | 91% | 10984.72 | 234 / 258 | 40% | 46.76 | 91 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 169.13 | 29 / 29 |
spleen | 100% | 21446.18 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 156.32 | 1 / 1 |
adipose | 100% | 49111.48 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 40423.36 | 1329 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 264.21 | 44 / 45 |
peripheral blood | 94% | 26631.67 | 876 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 89% | 87.79 | 71 / 80 |
heart | 70% | 12607.73 | 604 / 861 | 0% | 0 | 0 / 0 |
muscle | 56% | 6342.38 | 450 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0045577 | Biological process | regulation of B cell differentiation |
GO_0010468 | Biological process | regulation of gene expression |
GO_0071560 | Biological process | cellular response to transforming growth factor beta stimulus |
GO_0006397 | Biological process | mRNA processing |
GO_0008283 | Biological process | cell population proliferation |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0043488 | Biological process | regulation of mRNA stability |
GO_0051028 | Biological process | mRNA transport |
GO_0000165 | Biological process | MAPK cascade |
GO_0007507 | Biological process | heart development |
GO_0045647 | Biological process | negative regulation of erythrocyte differentiation |
GO_0071364 | Biological process | cellular response to epidermal growth factor stimulus |
GO_0060710 | Biological process | chorio-allantoic fusion |
GO_0035264 | Biological process | multicellular organism growth |
GO_0001570 | Biological process | vasculogenesis |
GO_0045657 | Biological process | positive regulation of monocyte differentiation |
GO_0061158 | Biological process | 3'-UTR-mediated mRNA destabilization |
GO_0045616 | Biological process | regulation of keratinocyte differentiation |
GO_0031086 | Biological process | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay |
GO_0048382 | Biological process | mesendoderm development |
GO_0006417 | Biological process | regulation of translation |
GO_0097403 | Biological process | cellular response to raffinose |
GO_0033077 | Biological process | T cell differentiation in thymus |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_1900153 | Biological process | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
GO_0072091 | Biological process | regulation of stem cell proliferation |
GO_0071320 | Biological process | cellular response to cAMP |
GO_1904582 | Biological process | positive regulation of intracellular mRNA localization |
GO_0070371 | Biological process | ERK1 and ERK2 cascade |
GO_0071375 | Biological process | cellular response to peptide hormone stimulus |
GO_0045600 | Biological process | positive regulation of fat cell differentiation |
GO_0071472 | Biological process | cellular response to salt stress |
GO_0043491 | Biological process | phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0003342 | Biological process | proepicardium development |
GO_0006915 | Biological process | apoptotic process |
GO_1901991 | Biological process | negative regulation of mitotic cell cycle phase transition |
GO_0000288 | Biological process | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
GO_0071385 | Biological process | cellular response to glucocorticoid stimulus |
GO_1902172 | Biological process | regulation of keratinocyte apoptotic process |
GO_0038066 | Biological process | p38MAPK cascade |
GO_0021915 | Biological process | neural tube development |
GO_0010837 | Biological process | regulation of keratinocyte proliferation |
GO_0045661 | Biological process | regulation of myoblast differentiation |
GO_0009611 | Biological process | response to wounding |
GO_0044344 | Biological process | cellular response to fibroblast growth factor stimulus |
GO_0071456 | Biological process | cellular response to hypoxia |
GO_0031440 | Biological process | regulation of mRNA 3'-end processing |
GO_0000932 | Cellular component | P-body |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0071889 | Molecular function | 14-3-3 protein binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0035925 | Molecular function | mRNA 3'-UTR AU-rich region binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ZFP36L1 |
Protein name | ZFP36 ring finger protein like 1 mRNA decay activator protein ZFP36 (Zinc finger protein 36) mRNA decay activator protein ZFP36L1 (Butyrate response factor 1) (EGF-response factor 1) (ERF-1) (TPA-induced sequence 11b) (Zinc finger protein 36, C3H1 type-like 1) (ZFP36-like 1) |
Synonyms | BRF1 RNF162B ERF1 BERG36 TIS11B |
Description | FUNCTION: Zinc-finger RNA-binding protein that destabilizes several cytoplasmic AU-rich element (ARE)-containing mRNA transcripts by promoting their poly(A) tail removal or deadenylation, and hence provide a mechanism for attenuating protein synthesis . Acts as a 3'-untranslated region (UTR) ARE mRNA-binding adapter protein to communicate signaling events to the mRNA decay machinery . Functions by recruiting the CCR4-NOT deadenylase complex and components of the cytoplasmic RNA decay machinery to the bound ARE-containing mRNAs, and hence promotes ARE-mediated mRNA deadenylation and decay processes . Induces also the degradation of ARE-containing mRNAs even in absence of poly(A) tail (By similarity). Binds to 3'-UTR ARE of numerous mRNAs . Positively regulates early adipogenesis by promoting ARE-mediated mRNA decay of immediate early genes (IEGs) (By similarity). Promotes ARE-mediated mRNA decay of mineralocorticoid receptor NR3C2 mRNA in response to hypertonic stress . Negatively regulates hematopoietic/erythroid cell differentiation by promoting ARE-mediated mRNA decay of the transcription factor STAT5B mRNA . Positively regulates monocyte/macrophage cell differentiation by promoting ARE-mediated mRNA decay of the cyclin-dependent kinase CDK6 mRNA . Promotes degradation of ARE-containing pluripotency-associated mRNAs in embryonic stem cells (ESCs), such as NANOG, through a fibroblast growth factor (FGF)-induced MAPK-dependent signaling pathway, and hence attenuates ESC self-renewal and positively regulates mesendoderm differentiation (By similarity). May play a role in mediating pro-apoptotic effects in malignant B-cells by promoting ARE-mediated mRNA decay of BCL2 mRNA . In association with ZFP36L2 maintains quiescence on developing B lymphocytes by promoting ARE-mediated decay of several mRNAs encoding cell cycle regulators that help B cells progress through the cell cycle, and hence ensuring accurate variable-diversity-joining (VDJ) recombination and functional immune cell formation (By similarity). Together with ZFP36L2 is also necessary for thymocyte development and prevention of T-cell acute lymphoblastic leukemia (T-ALL) transformation by promoting ARE-mediated mRNA decay of the oncogenic transcription factor NOTCH1 mRNA (By similarity). Participates in the delivery of target ARE-mRNAs to processing bodies (PBs) . In addition to its cytosolic mRNA-decay function, plays a role in the regulation of nuclear mRNA 3'-end processing; modulates mRNA 3'-end maturation efficiency of the DLL4 mRNA through binding with an ARE embedded in a weak noncanonical polyadenylation (poly(A)) signal in endothelial cells . Also involved in the regulation of stress granule (SG) and P-body (PB) formation and fusion . Plays a role in vasculogenesis and endocardial development (By similarity). Plays a role in the regulation of keratinocyte proliferation, differentiation and apoptosis . Plays a role in myoblast cell differentiation (By similarity). . FUNCTION: Zinc-finger RNA-binding protein that destabilizes several cytoplasmic AU-rich element (ARE)-containing mRNA transcripts by promoting their poly(A) tail removal or deadenylation, and hence provide a mechanism for attenuating protein synthesis. Acts as a 3'-untranslated region (UTR) ARE mRNA-binding adapter protein to communicate signaling events to the mRNA decay machinery. Functions by recruiting the CCR4-NOT deadenylase complex and probably other components of the cytoplasmic RNA decay machinery to the bound ARE-containing mRNAs, and hence promotes ARE-mediated mRNA deadenylation and decay processes. Binds to 3'-UTR ARE of numerous mRNAs. . FUNCTION: Zinc-finger RNA-binding protein that destabilizes several cytoplasmic AU-rich element (ARE)-containing mRNA transcripts by promoting their poly(A) tail removal or deadenylation, and hence provide a mechanism for attenuating protein synthesis. Acts as a 3'-untranslated region (UTR) ARE mRNA-binding adapter protein to communicate signaling events to the mRNA decay machinery. Functions by recruiting the CCR4-NOT deadenylase complex and probably other components of the cytoplasmic RNA decay machinery to the bound ARE-containing mRNAs, and hence promotes ARE-mediated mRNA deadenylation and decay processes. Binds to 3'-UTR ARE of numerous mRNAs. . |
Accessions | G3V515 G3V2D5 ENST00000557086.1 G3V2P5 Q07352 ENST00000336440.4 ENST00000557022.1 ENST00000553375.1 ENST00000439696.3 |